HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,606,952 | -62.9% | 143,547 | -67.0% | 0.02% | -64.7% |
| Q2 2023 | $44,728,334 | +1323.7% | 434,889 | +1410.8% | 0.07% | +1260.0% |
| Q1 2023 | $3,141,704 | +100.9% | 28,786 | +109.5% | 0.01% | +66.7% |
| Q4 2022 | $1,563,953 | -11.3% | 13,743 | -51.8% | 0.00% | 0.0% |
| Q3 2022 | $1,764,000 | +197.0% | 28,500 | +282.9% | 0.00% | +200.0% |
| Q2 2022 | $594,000 | +73.7% | 7,443 | +129.5% | 0.00% | – |
| Q1 2022 | $342,000 | -93.0% | 3,243 | -92.8% | 0.00% | -100.0% |
| Q4 2021 | $4,880,000 | +940.5% | 45,281 | +957.5% | 0.01% | +400.0% |
| Q3 2021 | $469,000 | -8.4% | 4,282 | -21.6% | 0.00% | 0.0% |
| Q2 2021 | $512,000 | -57.3% | 5,464 | -58.1% | 0.00% | -50.0% |
| Q1 2021 | $1,200,000 | +74.4% | 13,034 | +38.6% | 0.00% | +100.0% |
| Q4 2020 | $688,000 | -24.7% | 9,402 | -20.1% | 0.00% | -50.0% |
| Q3 2020 | $914,000 | -47.5% | 11,760 | -62.5% | 0.00% | -50.0% |
| Q2 2020 | $1,742,000 | +276.2% | 31,339 | +100.4% | 0.00% | +300.0% |
| Q1 2020 | $463,000 | -60.1% | 15,635 | -51.2% | 0.00% | -50.0% |
| Q4 2019 | $1,159,000 | +79.7% | 32,022 | +35.1% | 0.00% | +100.0% |
| Q3 2019 | $645,000 | -92.5% | 23,700 | -93.4% | 0.00% | -94.1% |
| Q2 2019 | $8,646,000 | – | 359,331 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |